(Q34732832)

4 August 2017

0 references

Influence of treatment on the clinical course of pemphigus vulgaris (English)

1 reference

4 August 2017

1 reference

pemphigus vulgaris

1 reference

Carson PJ

1

1 reference

4 August 2017

Hameed A

series ordinal

2

1 reference

4 August 2017

Ahmed AR

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

Journal of the American Academy of Dermatology

4 August 2017

1 reference

4 August 2017

34

1 reference

4 August 2017

4

1 reference

4 August 2017

645-652

1 reference

Pemphigus vulgaris; a study of the blood picture

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Therapeutic value of chloramphenicol in a group of dermatoses of established or questionable virus etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Pemphigus vlugaris; a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Pemphigus and pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Pituitary adrenocorticotropic hormone (ACTH) and cortisone in diseases of the skin. I. Pemphigus vulgaris and other bullous dermatoses

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Effects of ACTH and cortisone on certain diseases and physiologic functions of the skin: I. Effects of ACTH.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Corticotropin (ACTH) and cortisone in treatment of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Effect of aureomycin, chloromycetin, and terramycin on pemphigus vulgaris during treatment with adrenocorticotrophic hormone (ACTH)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Treatment of pemphigus with cortisone by mouth

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Prolonged therapy with cortisone for chronic skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Some aspects of the physiological effects of cortisone in the treatment of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Cortisone and corticotropin treatment of pemphigus; experience with twenty-eight cases over a period of five years

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Prednisone in treatment of selected dermatoses; preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

The management and complications of steroid therapy for pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Long-term management of pemphigus vulgaris with corticotropin (ACTH)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

The treatment of pemphigus and erythroderma with corticotropin and cortisone

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Pemphigus vulgaris with lesions of the rectal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Fatal amebiasis complicating corticosteroid management of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Corticosteroid treatment of pemphigus. Experience with fifty cases over a period of ten years

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Treatment in bullous diseases with corticosteroid drugs and corticotrophin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Treatment of pemphigus with corticosteroids. Results obtained in 46 patients over a period of 11 years

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Pemphigus vulgaris—report of six cases including a good response with oestrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Alternate-day prednisone therapy for pemphigus vulgaris. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

The role of immunofluorescence in the diagnosis of oral vesiculobullous disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Familial occurrence of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Pemphigus vulgaris successfully treated with cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Treatment of Pemphigus Vulgaris With Methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Azathioprine in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Immunosuppressants in the treatment of pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Pemphigus Vulgaris Treated With Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Gold sodium thiomalate treatment of pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Treatment of pemphigus and pemphigoid with azathioprine.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Azathioprine for pemphigus and pemphigoid--a 4 year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Letter: Gold treatment of pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Gold therapy for pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Prednisone and azathioprine in the treatment of patient with vesiculoerosive oral diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Oral gold therapy (Auranofin) in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Use of cyclophosphamide in azathioprine failures in pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Remote Results of Continuous Systemic Corticosteroid Treatment in Pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Effects of cyclosporin on bullous pemphigoid and pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Treatment of nine cases of pemphigus vulgaris with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Treatment of pemphigus vulgaris with cyclosporine. .

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Pemphigus vulgaris and plasma exchange: clinical and serologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Dapsone in the Treatment of Pemphigus Vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Contributions to the study of pemphigus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

Treatment of pemphigus with corticosteroids; study of fifty-two patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2980066-1

7 January 2021

10.1016/S0190-9622(96)80066-1

Identifiers

DOI

1 reference

4 August 2017

1 reference